Literature DB >> 11699482

Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?

S Séguier1, B Gogly, A Bodineau, G Godeau, N Brousse.   

Abstract

BACKGROUND: Evidence of the role of matrix metalloproteinases (MMPs) produced by resident and inflammatory cells in periodontal destruction is now well established. The purpose of this study was to quantify, in healthy and diseased upper gingival connective tissue, the area fraction (AA%) occupied by collagen fibers, the cell number belonging to inflammatory cell subsets, and the amounts of MMPs and TIMPs (tissue inhibitors of MMPs) in order to investigate the possible correlations, if any, between such molecules, collagen loss, and inflammatory cell subsets.
METHODS: Gingival tissue specimens from 6 healthy controls (C) and 6 patients with severe periodontitis (P) were divided into 2 groups. The first group of specimens was frozen and used for the staining of collagen fibers by sirius red F3Ba and for immunohistochemistry with antibodies against CD8, CD4, CD22, CD68, and TIA-1 molecules. The second group was used for organ culture, zymography, Western blotting, and dot blotting. Morphometric and automated image analysis was performed for the evaluation of the area fraction occupied by collagen fibers, the number of inflammatory cell subsets and for enzymatic activities developed by MMPs, and the amounts of TIMPs expressed during periodontal disease.
RESULTS: In group P, the area fraction of collagen fibers (33 +/- 10%) was significantly decreased (P < 0.0002) when compared to group C (60 +/- 7%), and was correlated with the number of all inflammatory cells and amounts of MMPs and TIMPs. In group P, there were significant increases of CD8+, CD22+, CD68+, and TIA-1+ cells, as well as increases in the amounts of MMP-1, MMP-2, MMP-3, MMP-9, and the active form of MMP-9. The active form of MMP-9 and the amount of TIMP-1 were positively correlated with the number of CD22+, CD68+, and TIA-1+ cells.
CONCLUSIONS: The present study showed an imbalance between MMPs and TIMPs associated with the pathologic breakdown of the extracellular matrix during periodontitis. The active form of MMP-9 could be a marker for the clinical severity of periodontal disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699482     DOI: 10.1902/jop.2001.72.10.1398

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  20 in total

1.  GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.

Authors:  Roselind S Lam; Neil M O'Brien-Simpson; John A Hamilton; Jason C Lenzo; James A Holden; Gail C Brammar; Rebecca K Orth; Yan Tan; Katrina A Walsh; Andrew J Fleetwood; Eric C Reynolds
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

2.  The Treponema denticola chymotrypsin-like protease dentilisin induces matrix metalloproteinase-2-dependent fibronectin fragmentation in periodontal ligament cells.

Authors:  Di Miao; J Christopher Fenno; John C Timm; Nam Eok Joo; Yvonne L Kapila
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

3.  Local Inflammation Alters MMP-2 and MMP-9 Gelatinase Expression Associated with the Severity of Nifedipine-Induced Gingival Overgrowth: a Rat Model Study.

Authors:  Wu-Li Li; Cheng-Hai Wu; Jun Yang; Min Tang; Long-Jie Chen; Shou-Liang Zhao
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

4.  Peptoanaerobacter stomatis Primes Human Neutrophils and Induces Granule Exocytosis.

Authors:  E Jimenez Flores; S Tian; M Sizova; S S Epstein; R J Lamont; S M Uriarte
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

5.  Effects of a vegetable extract from Lupinus albus (LU105) on the production of matrix metalloproteinases (MMP1, MMP2, MMP9) and tissue inhibitor of metalloproteinases (TIMP1, TIMP2) by human gingival fibroblasts in culture.

Authors:  F Gaultier; A Foucault-Bertaud; E Lamy; A L Ejeil; S M Dridi; N Piccardi; A Piccirilli; P Msika; G Godeau; B Gogly
Journal:  Clin Oral Investig       Date:  2003-06-07       Impact factor: 3.573

6.  The expression and regulation of matrix metalloproteinase-3 is critically modulated by Porphyromonas gingivalis lipopolysaccharide with heterogeneous lipid A structures in human gingival fibroblasts.

Authors:  Thanuja D K Herath; Yu Wang; Chaminda J Seneviratne; Richard P Darveau; Cun-Yu Wang; Lijian Jin
Journal:  BMC Microbiol       Date:  2013-03-30       Impact factor: 3.605

7.  Elastase and metalloproteinase-9 concentrations in saliva in patients with chronic periodontitis.

Authors:  Małgorzata Nędzi-Góra; Jolanta Kostrzewa-Janicka; Renata Górska
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

Review 8.  The role of osteoimmunology in periodontal disease.

Authors:  Rayyan A Kayal
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

9.  Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease.

Authors:  Esther Nalini Honibald; Sebeena Mathew; Jeyantha Padmanaban; Elanchezhiyan Sundaram; Renuka Devi Ramamoorthy
Journal:  J Pharm Bioallied Sci       Date:  2012-08

10.  Proteolytic Activities of Oral Bacteria on ProMMP-9 and the Effect of Synthetic Proteinase Inhibitors.

Authors:  Guang Jie Bao; Kirsti Kari; Taina Tervahartiala; Timo Sorsa; Jukka H Meurman
Journal:  Open Dent J       Date:  2008-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.